Gavin Churchyard

The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study

Wouter Hoefsloot, Jakko van Ingen, Claire Andréjak et al. · European Respiratory Journal · 2013 · 858 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis

Andreas H. Diacon, Alexander S. Pym, Martin P. Grobusch et al. · New England Journal of Medicine · 2009 · 839 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis

Amina Jindani, Thomas S. Harrison, Andrew Nunn et al. · New England Journal of Medicine · 2014 · 444 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study

Glenda Gray, Mary Allen, Zoe Moodie et al. · The Lancet Infectious Diseases · 2011 · 385 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

Martin J. Boeree, Norbert Heinrich, Rob E. Aarnoutse et al. · The Lancet Infectious Diseases · 2016 · 385 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13